A Medical Device Daily
American Bio Medica (Kinderhook, New York) reported that it has been granted two U.S. patents; one for its oral fluid drug-testing product line and the other for its all inclusive urine point-of-collection drug test cup product line.
U.S. patent No. 7,507,374 relates to the testing of a saliva sample for drugs of abuse, more particularly to a device and process that permits the saliva sample to be treated and incubated for a predetermined period of time prior to being introduced to an immunoassay test strip.
U.S. patent No. 7,507,373 covers the company's all-inclusive cup product line and relates to an assay device for the testing of liquid samples for determining the presence of undesirable constituents, more particularly to a test device having a container for retaining a liquid sample and test strips within the container for indicating visually the presence of particular drugs of abuse.
With these patents, American Bio's intellectual property portfolio for its drug of abuse testing line increases to 10 U.S. patents and 14 foreign patents, in addition to a number of pending patent applications both within the U.S. and internationally, the company noted.